Company intelligence / Profile preview

PRV Fund Project

New York City, New York, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

The PRV Fund Project is an active initiative providing non-dilutive funding to early-stage biopharma and biotech companies focused on developing treatments for rare pediatric-onset diseases. It aims to accelerate innovation in areas with significant unmet medical need by leveraging the U.S. FDA’s Priority Review Voucher program as an incentive mechanism.

Therapeutic areas: Rare Diseases
Industry: Investors

Partnerships

Collaborates with early-stage biotech/biopharma firms seeking non-dilutive capital

Beyond the preview

Go deeper on PRV Fund Project.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRV Fund Project.

Explore the full profile